Last $0.01 USD
Change Today +0.0006 / 5.04%
Volume 1.3M
SCIE On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

spectrascience inc (SCIE) Snapshot

Open
$0.01
Previous Close
$0.01
Day High
$0.01
Day Low
$0.01
52 Week High
04/25/14 - $0.10
52 Week Low
10/7/14 - $0.01
Market Cap
2.2M
Average Volume 10 Days
313.3K
EPS TTM
$-0.04
Shares Outstanding
173.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SPECTRASCIENCE INC (SCIE)

Related News

No related news articles were found.

spectrascience inc (SCIE) Related Businessweek News

No Related Businessweek News Found

spectrascience inc (SCIE) Details

SpectraScience, Inc. develops and markets a technology platform to instantly determine whether a tissue is normal, pre-cancerous, or cancerous without the need for a physical biopsy. It offers WavSTAT4 Optical Biopsy System, a minimally invasive technology system that operates by using UV laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer. The company also sells WavSTAT4 mobile consoles and disposable forceps. SpectraScience, Inc. sells its system for colon cancer detection in the European Union. The company was formerly known as GV Medical, Inc. and changed its name to SpectraScience, Inc. in October 1992. SpectraScience, Inc. was founded in 1983 and is based in San Diego, California.

spectrascience inc (SCIE) Top Compensated Officers

Chief Executive Officer, President, Chief Ope...
Total Annual Compensation: $197.0K
Compensation as of Fiscal Year 2013.

spectrascience inc (SCIE) Key Developments

Spectrascience Inc. Presents at 8th Annual OneMedForum 2015, Jan-12-2015 10:30 AM

Spectrascience Inc. Presents at 8th Annual OneMedForum 2015, Jan-12-2015 10:30 AM. Venue: San Francisco Marriott Marquis, Parc 55 Wyndham, Union Square, San Francisco, California, United States.

Spectrascience Inc. Appoints Rand Mulford to its Board

Spectrascience Inc. announced that its Board of Directors has appointed Rand Mulford to its Board. Rand is an independent consultant with a depth of experience in assisting organizations in developing overall strategy and conducting corporate financing and development programs. For the past five years, Mr. Mulford has successfully completed a variety of projects including managing M&A transactions, developing strategy for companies in therapeutic antibodies, cell-based therapy for eye diseases, prescription drug distribution, and developing a potential cure for AIDS. Previously, Mr. Mulford had joined with two other partners to found a specialty pharmaceutical company.

Spectrascience Inc. Presents at LD Micro Conference, Dec-03-2014 09:30 AM

Spectrascience Inc. Presents at LD Micro Conference, Dec-03-2014 09:30 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Michael P. Oliver, Chief Executive Officer, President, Chief Operating Officer and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SCIE:US $0.01 USD +0.0006

SCIE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
MELA Sciences Inc $1.41 USD -0.06
View Industry Companies
 

Industry Analysis

SCIE

Industry Average

Valuation SCIE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 34.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SPECTRASCIENCE INC, please visit www.spectrascience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.